verbal numberical rating score adverse effects Postoperative pain relief chronic pain arthroscopic shoulder surgery interscalene brachial plexus block parecoxib
Conditions
Interventions
patients in this arm will receive paracoxib 40 mg iv 1-
2 hrs before operation and another 40 mg after the first dose,patients in this arm will receive NSS 2 ml iv 1-
2 hrs before operation and another 2 ml after the first dose
Experimental Drug,Placebo Comparator No treatment
Sponsors
Prince of Songkla University
Prince of Songkla University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Eligible patients are those aged 18 65 years of either sex American Society of Anesthesiologists ASA physical status I II and body mass index BMI between 16 35
Exclusion criteria
Exclusion criteria: The exclusion criteria are patients who are allergic to sulfonamides or celecoxib with impaired hepatic or renal functions alcohol or substance abuse chronic pain except pain in the shoulder or daily intake of analgesics uncontrolled medical disease hypertension and diabetes mellitus and inability to communicate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amout of postoperative PCA morphine consumption medical record | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of chronic pain medical records | — |
Countries
Thailand
Contacts
Public ContactSasikaan Nimmaanrat
Prince of Songkla University
Outcome results
None listed